TipRanks
NanoViricides (NNVC)
:NNVC
US Market
Want to see NNVC full AI Analyst Report?

NanoViricides (NNVC) Financial Statements

652 Followers

NanoViricides Financial Overview

NanoViricides's market cap is currently $34.71M. The company's EPS TTM is $-0.4121; its P/E ratio is -3.30; NanoViricides is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -525.29K$ 0.00$ 0.00$ -747.53K$ 0.00
Operating Income$ -8.31M$ -9.59M$ -8.52M$ -8.94M$ -8.11M
EBITDA$ -7.78M$ -8.72M$ -7.49M$ -7.84M$ -7.38M
Net Income$ -8.22M$ -9.47M$ -8.29M$ -8.59M$ -8.11M
Balance Sheet
Cash & Short-Term Investments$ 2.79M$ 1.56M$ 4.80M$ 8.15M$ 14.07M
Total Assets$ 9.87M$ 8.82M$ 12.82M$ 16.90M$ 23.49M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 94.79K
Net Debt$ -2.79M$ -1.56M$ -4.80M$ -8.15M$ -13.97M
Total Liabilities$ 1.19M$ 1.31M$ 1.36M$ 2.03M$ 412.84K
Stockholders' Equity$ 8.68M$ 7.52M$ 11.46M$ 14.87M$ 23.08M
Cash Flow
Free Cash Flow$ -7.78T$ -8.54M$ -6.47M$ -5.82M$ -6.22M
Operating Cash Flow$ -7.70T$ -8.48M$ -6.32M$ -5.67M$ -5.89M
Investing Cash Flow$ -84.32B$ -56.96K$ -156.56K$ -151.71K$ -324.35K
Financing Cash Flow$ 9.02T$ 5.30M$ 3.12M$ -94.79K$ -234.72K
Currency in USD

NanoViricides Earnings and Revenue History

NanoViricides Debt to Assets

NanoViricides Cash Flow

NanoViricides Forecast EPS vs Actual EPS